Your browser doesn't support javascript.
loading
Enhanced protease cleavage efficiency on the glucagon-fused interleukin-2 by the addition of synthetic oligopeptides.
Kim, Sung-Woo; Kim, Jae-Bum; Lee, Weon Sup; Jung, Woo-Hyuk; Ryu, Ji-Myung; Jang, Hyung-Wook; Jo, Young-Bae; Jung, Joon-Ki; Kim, Jung-Hoe.
Afiliação
  • Kim SW; AceBiotech Co., Ltd., #114 Bio-Venture Center (BVC), KRIBB, Yuseong, Daejeon 305-806, Republic of Korea.
Protein Expr Purif ; 55(1): 159-65, 2007 Sep.
Article em En | MEDLINE | ID: mdl-17512753
ABSTRACT
Human interleukin-2 (hIL-2) was produced as a recombinant fusion protein (G3.IL-2/HF) consisting of three tandem-arranged human glucagon molecules (G3) and hIL-2. For the recovery of hIL-2, a factor Xa (FXa) cleavage sequence was introduced next to the N-terminus of hIL-2. Cleavage efficiency on this recombinant protein construct was very low because its recognition sequence was sterically hindered within the G3.IL-2/HF molecule and hence FXa access to the cleavage site was insufficient. We therefore introduced various synthetic oligopeptides upstream from the FXa cleavage site as a means to change substrate conformation and thereby increase cleavage efficiency. Among these oligopeptides, acidic or nucleophilic constructs were the most effective for the FXa-mediated cleavage of the fusion protein. In addition, insertion of various oligopeptides into the G3.IL-2/HF molecule varied the solubility of each construct depending on their physical properties. Consequently, the G3.IL-2/DF construct showed the highest final hIL-2 yields via FXa-mediated removal of the fusion partner. Lastly, we confirmed that cleavage efficiency was greatly increased but native hIL-2 was cleaved internally by non-specific cleavage when the acidic oligopeptide D4 (DDDD) was introduced upstream of the EK cleavage site within G3.IL-2/HE molecule. The G3.IL-2/HE molecule was shown to be an inefficient substrate to EK in a previous report (Biotechnol. Bioprocess Eng. (2000) 5, 13-16).
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Glucagon / Cisteína Endopeptidases / Interleucina-2 / Proteínas de Neoplasias Idioma: En Ano de publicação: 2007 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Glucagon / Cisteína Endopeptidases / Interleucina-2 / Proteínas de Neoplasias Idioma: En Ano de publicação: 2007 Tipo de documento: Article